Staff Profile
Dr Svetlana Cherlin
Senior Research Associate
- Address: Population Health Sciences Institute
Ridley Building 1 (4th Floor)
Queen Victoria Road
Newcastle upon Tyne
NE1 7RU
www.newcastle-biostatistics.com
Publications
-
Articles
- Morton M, Wilson N, Homer TM, Simms L, Steel A, Maier R, Wason J, Ternent L, Abouhajar A, Allen M, Joyce R, Hildreth V, Lakey R, Cherlin S, Walker A, Devereux G, Chalmers JD, Hill AT, Haworth C, Hurst JR, De Soyza A. Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis. BMJ Open 2023, 13(8), e071906.
- Grayling MJ, Bigirumurame T, Cherlin S, Ouma L, Zheng H, Wason JMS. Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential. BMC Rheumatology 2021, 5, 21.
- Cherlin S, Wason JMS. Developing a predictive signature for two trial endpoints using the cross-validated risk scores method. Biostatistics 2021, 21(2), 598-617.
- Castellucci LC, Almeida L, Cherlin S, Fakiola M, Francis RW, Carvalho EM, Santos da Hora A, do Lago TS, Figueiredo AB, Cavalcanti CM, Alves NS, Morais KLP, Teixeira-Carvalho A, Dutra WO, Gollob KJ, Cordell HJ, Blackwell JM. A Genome-wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis in Brazil. Clinical Infectious Diseases 2021, 72(10), e515-e525.
- Cherlin S, Lewis MJ, Plant D, Nair N, Goldmann K, Tzanis E, Barnes MR, McKeigue P, Barrett JH, Pitzalis C, Barton A, Cordell HJ. Investigation of genetically-regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response. Annals of the Rheumatic Diseases 2020, 79(11), 1446-1452.
- Heaps SE, Nye TMW, Boys RJ, Williams TA, Cherlin S, Embley TM. Generalizing rate heterogeneity across sites in statistical phylogenetics. Statistical Modelling 2020, 20(4), 410-436.
- Cherlin S, Wason JMS. Developing and testing high‐efficacy patient subgroups within a clinical trial using risk scores. Statistics in Medicine 2020, 39(24), 3285-3298.
- Cherlin S, Heaps SE, Nye TMW, Boys RJ, Williams TA, Embley TM. The effect of nonreversibility on inferring rooted phylogenies. Molecular Biology and Evolution 2018, 35(4), 984-1002.
- Cherlin S, Plant D, Taylor JC, Colombo M, Spiliopoulou A, Tzanis E, Morgan AW, Barnes MR, McKeigue P, Barrett JH, Pitzalis C, Barton A, Cordell HJ. Prediction of treatment response in rheumatoid arthritis patients using genome‐wide SNP data. Genetic Epidemiology 2018, 42(8), 754-771.
- Cherlin S, Wang MH, Bickeboller H, Cantor RM. Detecting responses to treatment with fenofibrate in pedigrees. BMC Genetics 2018, 19(Suppl. 1), 64.
- Williams TA, Heaps SE, Cherlin S, Nye TMW, Boys RJ, Embley TM. New substitution models for rooting phylogenetic trees. Philosophical Transactions of the Royal Society B: Biological Sciences 2015, 370(1678), 20140336.
-
Conference Proceedings (inc. Abstract)
- Cherlin S, Howey RAJ, Cordell HJ. Using penalized regression to predict phenotype from SNP data. In: Genetic Analysis Workshop 20. 2018, San Diego, CA, USA: BioMed Central Ltd.
-
Letter
- Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial. Trials 2021, 22(1), 270.